Fennec Pharmaceuticals Inc.

NasdaqCM:FENC 株式レポート

時価総額:US$184.7m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Fennec Pharmaceuticals バランスシートの健全性

財務の健全性 基準チェック /46

Fennec Pharmaceuticalsの総株主資本は$3.0M 、総負債は$31.3Mで、負債比率は1040.1%となります。総資産と総負債はそれぞれ$69.2Mと$66.2Mです。 Fennec Pharmaceuticalsの EBIT は$6.2Mで、利息カバレッジ比率1.9です。現金および短期投資は$51.2Mです。

主要情報

1,040.1%

負債資本比率

US$31.35m

負債

インタレスト・カバレッジ・レシオ1.9x
現金US$51.18m
エクイティUS$3.01m
負債合計US$66.18m
総資産US$69.19m

財務の健全性に関する最新情報

Recent updates

Lacklustre Performance Is Driving Fennec Pharmaceuticals Inc.'s (NASDAQ:FENC) 27% Price Drop

Jun 02
Lacklustre Performance Is Driving Fennec Pharmaceuticals Inc.'s (NASDAQ:FENC) 27% Price Drop

Risks To Shareholder Returns Are Elevated At These Prices For Fennec Pharmaceuticals Inc. (NASDAQ:FENC)

Apr 18
Risks To Shareholder Returns Are Elevated At These Prices For Fennec Pharmaceuticals Inc. (NASDAQ:FENC)

Earnings Update: Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Just Reported And Analysts Are Boosting Their Estimates

Nov 09
Earnings Update: Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Just Reported And Analysts Are Boosting Their Estimates

Fennec wins FDA approval of Pedmark for chemotherapy-induced ototoxicity in children

Sep 20

Buying Fennec Pharma Ahead Of September PDUFA For Pedmark

Aug 23

Fennec Pharmaceuticals secures up to $45M financing facility from Petrichor

Aug 01

Fennec Pharmaceuticals: Will Pedmark Make It To Market At Second Time Of Asking?

Oct 29

Fennec Could See Upside If Pedmark Gets Approved

Jul 29

Fennec Pharmaceuticals (FENC) Investor Presentation - Slideshow

Jun 18

Fennec Pharma resubmits PEDMARK application in U.S.

May 28

Fennec Pharmaceuticals (NASDAQ:FENC) Is In A Good Position To Deliver On Growth Plans

May 26
Fennec Pharmaceuticals (NASDAQ:FENC) Is In A Good Position To Deliver On Growth Plans

Breakeven On The Horizon For Fennec Pharmaceuticals Inc. (NASDAQ:FENC)

Apr 01
Breakeven On The Horizon For Fennec Pharmaceuticals Inc. (NASDAQ:FENC)

Do Institutions Own Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Shares?

Mar 02
Do Institutions Own Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Shares?

Have Insiders Been Selling Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Shares This Year?

Jan 26
Have Insiders Been Selling Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Shares This Year?

Companies Like Fennec Pharmaceuticals (NASDAQ:FENC) Are In A Position To Invest In Growth

Dec 22
Companies Like Fennec Pharmaceuticals (NASDAQ:FENC) Are In A Position To Invest In Growth

Fennec Pharmaceuticals EPS misses by $0.05

Nov 16

Fennec Pharmaceuticals: The Compensation Is What's Missing

Nov 05

財務状況分析

短期負債: FENCの 短期資産 ( $68.2M ) が 短期負債 ( $9.8M ) を超えています。

長期負債: FENCの短期資産 ( $68.2M ) が 長期負債 ( $56.3M ) を上回っています。


デット・ツー・エクイティの歴史と分析

負債レベル: FENC総負債よりも多くの現金を保有しています。

負債の削減: FENCの負債対資本比率は、過去 5 年間で0%から1040.1%に増加しました。

債務返済能力: FENCの負債は 営業キャッシュフロー によって 十分にカバー されています ( 87.7% )。

インタレストカバレッジ: FENCの負債に対する 利息支払いEBIT ( 1.9 x coverage) によって 十分にカバーされていません


貸借対照表


健全な企業の発掘